Genix Pharmaceuticals Corporation (TSXV:GENX)

Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
At close: Mar 5, 2026
Market Cap1.22M -87.8%
Revenue (ttm)n/a
Net Income-335.06K
EPS-0.01
Shares Out61.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,100
Average Volume150,701
Open0.0200
Previous Close0.0200
Day's Range0.0200 - 0.0200
52-Week Range0.0200 - 0.0500
Beta0.49
RSI40.48
Earnings DateFeb 26, 2026

About Genix Pharmaceuticals

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal healt... [Read more]

Sector Healthcare
Founded 1993
Employees 4,000
Stock Exchange TSX Venture Exchange
Ticker Symbol GENX
Full Company Profile

Financial Performance

Financial Statements